CLINICAL SUPPLY MANAGEMENT ARTICLES
Managing Inbound Supply Risk With R3M In Clinical Supply Chains
Clinical supply chains face silent inbound disruptions. R3M offers a structured way to measure supplier risk, monitor signals early, and mitigate before trials are impacted.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Learn how the integral role of Direct-to-Patient Services plays a part in the execution of decentralized trials and how sponsors can maximize these benefits to improve drug development.
-
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
To better understand sponsors’ perspectives on DTP distribution of clinical supplies, 234 individuals involved in clinical supply and operations were recently surveyed. Click to get the results!
-
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
The pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
-
As clinical trials grow in complexity, discover how adopting adaptive, unified RTSM technology can help to reduce costs and maintain accurate, real-time study data.